Comparative Study
. 2007;124(2):319-32; discussion 330-2.
[Meningiomas: new prognostic factors]
[Article in
Spanish]
- PMID: 18069599
Item in Clipboard
Comparative Study
[Meningiomas: new prognostic factors]
[Article in
Spanish]
An R Acad Nac Med (Madr).
2007.
Abstract
Meningiomas are still defined as benignant tumours although 25% of those tumours will have local recurrance in the follow-up period. The WHO (2000) classification divides meningiomas in three goups: Grade 1 for conventional meningioma. Grade 2 for atypical meningioma and Grade 3 for Anaplastic meningioma. Specific histological variants of meningiomas have been included in grade 2 tumours. Clear cell, rabdoid and papillary meningiomas. We obtained 250 meningiomas from our files and we analyzed 30 inmunohistochemical markers. Several markers can be actually used as prognostic indicators in meningiomas and may allow a more individualized management of patients.
Similar articles
-
Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment.Strahlenther Onkol. 2006 Nov;182(11):641-6. doi: 10.1007/s00066-006-1555-3. Strahlenther Onkol. 2006. PMID: 17072521
-
Anaplastic meningioma: progression from atypical and chordoid morphotype with morphologic spectral variation at recurrence.Neuropathology. 2010 Jun;30(3):279-87. doi: 10.1111/j.1440-1789.2009.01060.x. Epub 2009 Sep 14. Neuropathology. 2010. PMID: 19780983
-
Osteopontin predicts the behaviour of atypical meningioma.Histopathology. 2012 Jan;60(2):320-5. doi: 10.1111/j.1365-2559.2011.04085.x. Histopathology. 2012. PMID: 22211290
-
[Problems in treatment for meningiomas].Nihon Rinsho. 2005 Sep;63 Suppl 9:303-9. Nihon Rinsho. 2005. PMID: 16201539 Review. Japanese. No abstract available.
-
Meningiomas.Lancet. 2004 May 8;363(9420):1535-43. doi: 10.1016/S0140-6736(04)16153-9. Lancet. 2004. PMID: 15135603 Review.